LY6G5B |
Q8NDX9
|
lymphocyte antigen 6 family member G5B
|
|
8.2E-06 |
0.931 |
0.192 |
LY6G5C |
Q5SRR4
|
lymphocyte antigen 6 family member G5C
|
|
0.41 |
0.931 |
0.192 |
GPANK1 |
O95872
|
G-patch domain and ankyrin repeats 1
|
|
3.2E-07 |
0.769 |
0.385 |
GPR183 |
P32249
|
G protein-coupled receptor 183
|
G-protein coupled receptor
|
1.7E-02 |
0.700 |
0.462 |
ITGB7 |
P26010
|
integrin subunit beta 7
|
Receptor
|
2.4E-06 |
0.729 |
0.462 |
EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
CSNK2B |
P67870
|
casein kinase 2 beta
|
Kinase
|
0.92 |
0.686 |
0.538 |
FGR |
P09769
|
FGR proto-oncogene, Src family tyrosine kinase
|
Kinase
|
0.48 |
0.647 |
0.615 |
BAG6 |
P46379
|
BAG cochaperone 6
|
Enzyme modulator
|
1.00 |
0.674 |
0.615 |
KLRG1 |
Q96E93
|
killer cell lectin like receptor G1
|
|
3.4E-03 |
0.653 |
0.615 |
CTSH |
P09668
|
cathepsin H
|
Enzyme
|
1.3E-08 |
0.626 |
0.654 |
FCER2 |
P06734
|
Fc fragment of IgE receptor II
|
Receptor
|
7.6E-12 |
0.560 |
0.654 |
HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
PRRC2A |
P48634
|
proline rich coiled-coil 2A
|
Enzyme
|
1.00 |
0.656 |
0.654 |
IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
MEPE |
Q9NQ76
|
matrix extracellular phosphoglycoprotein
|
|
8.6E-03 |
0.628 |
0.654 |
CD27 |
P26842
|
CD27 molecule
|
|
1.0E-02 |
0.517 |
0.692 |
CD48 |
P09326
|
CD48 molecule
|
|
1.7E-05 |
0.592 |
0.692 |
LTB4R |
Q15722
|
leukotriene B4 receptor
|
G-protein coupled receptor
|
0.12 |
0.576 |
0.692 |
PRF1 |
P14222
|
perforin 1
|
|
5.5E-06 |
0.540 |
0.692 |
VTCN1 |
Q7Z7D3
|
V-set domain containing T cell activation inhibitor 1
|
Enzyme modulator
|
1.4E-12 |
0.529 |
0.692 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |